Hangzhou, China

Hognlei Zhang

This inventor holds 1 USPTO granted patent. Top assignee: Hangzhou Tianlong Pharmaceutical Co., Ltd.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hognlei Zhang. Retrieved from https://idiyas.com/inventor/hognlei-zhang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hognlei Zhang: Innovator in Pharmaceutical Compounds

Introduction

Hognlei Zhang is a prominent inventor based in Hangzhou, China. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of innovative compounds. His work focuses on enhancing the delivery of therapeutic agents, which is crucial for effective medical treatments.

Latest Patents

Hognlei Zhang holds a patent for a cationic lipid compound, which is detailed in his patent titled "Cationic lipid compound, composition containing same and use thereof." This patent describes a compound of formula (I), or an N-oxide, solvate, pharmaceutically acceptable salt, or stereoisomer thereof. The patent also outlines a composition containing the aforementioned compound and its use in the delivery of therapeutic or prophylactic agents. He has 1 patent to his name.

Career Highlights

Hognlei Zhang is associated with Hangzhou Tianlong Pharmaceutical Co., Ltd., where he applies his expertise in pharmaceutical innovation. His work at the company has positioned him as a key player in the development of new medical solutions.

Collaborations

Hognlei Zhang collaborates with notable colleagues, including Gengshen Song and Huanyu Wang. Their combined efforts contribute to advancing research and development in the pharmaceutical sector.

Conclusion

Hognlei Zhang's innovative work in pharmaceutical compounds showcases his commitment to improving medical treatments. His contributions are vital for the ongoing advancement of therapeutic delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…